Ignite Creation Date:
2024-05-06 @ 2:41 PM
Last Modification Date:
2024-10-26 @ 1:35 PM
Study NCT ID:
NCT04398823
Status:
UNKNOWN
Last Update Posted:
2020-05-21
First Post:
2020-05-09
Brief Title:
A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal Hemorrhoids
Sponsor:
Xinhua Hospital Shanghai Jiao Tong University School of Medicine
Organization:
Xinhua Hospital Shanghai Jiao Tong University School of Medicine
Study Overview
Official Title:
A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal Hemorrhoids
Status:
UNKNOWN
Status Verified Date:
2020-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Internal hemorrhoid affects the quality of life due to hemorrhage and prolapse as a common and frequently-occurring disease Endoscopic sclerosing agent injection has replaced traditional surgery and become the most commonly used treatment method in developed countries At present how to reduce the side effects of sclerosing agent and accurately determine the injection site and depth has become a difficult clinical problem The research group creatively put forward the theory of foam sclerosing agent to treat internal hemorrhoids in the early stage With the aid of transparent cap the visibility of surgical field of vision can be improved The mini probe ultrasound MPS is proposed to effectively evaluate the submucosal in
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None